Topics

OncoCell MDx, Inc. Company Profile

04:42 EDT 16th September 2019 | BioPortfolio

OncoCell MDx, Inc. is a privately held immunogenomics platform company developing and commercializing novel noninvasive blood-based immunogenomic assays designed to aid physicians in better understanding underlying disease pathology in prostate cancer and other disease. The company’s proprietary technologies were created at Harvard Medical School by OncoCell MDx’s founder, Professor Amin I. Kassis. For more information about OncoCell MDx and its technology, visit: https://oncocellmdx.com/.


News Articles [9 Associated News Articles listed on BioPortfolio]

OncoCell MDx raises $22.2 million in series B financing

OncoCell MDx, a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, today announced it has raised $22.2 million in a Preferred Series B...

Funding round secures $22.2M for OncoCell MDx

A round of Series B funding has pulled in $22.2 million for liquid biopsy developer OncoCell MDx, which intends to market its -More- 

OncoCell MDx, Inc. Raises $22.2 Million in Series B Financing

Proceeds to Advance Liquid Biopsy Immunogenomics Platform OncoCell MDx, Inc., a pan-disease immunogenomics platform company developing novel noninvasive blood-based tests to optimize patient care, ...

OncoCell MDx Appoints Marc Stapley to its Board of Directors

OncoCell MDx, an immunogenomics platform company developing novel, noninvasive molecular diagnostic assays for cancer and other disease, today announced that Marc Stapley has joined the company’s B...

Liquid biopsy developer OncoCell MDx raises $22.2M in Series B round

The company plans to launch its prostate cancer test next year and has several papers it will to submit to journals in the next four to six months.

OncoCell MDx Appoints Renowned Urologic Pathologist as Chief Medical Officer

OncoCell MDx, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced that Kirk Wojno, M.D., has joined the company’s lead...

OncoCell MDx Prepares for Commercialization with Appointment of Christopher Thibodeau as Chief Operating Officer

OncoCell MDx™, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced the appointment of Christopher Thibodeau as its Chi...

OncoCell MDx Announces Mark McDonough as New President & Chief Executive Officer

OncoCell MDx, a company developing novel noninvasive diagnostic and prognostic tests by harnessing the power of the immune system, today announced the appointment of Mark McDonoug...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

OncoCell MDx, Inc.

OncoCell MDx, Inc. is a privately held immunogenomics platform company developing and commercializing novel noninvasive blood-based immunogenomic assays designed to aid physicians in better understan...

OncoCell MDx

OncoCell MDx is a privately held company developing and commercializing novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. The companyâ...

More Information about "OncoCell MDx, Inc." on BioPortfolio

We have published hundreds of OncoCell MDx, Inc. news stories on BioPortfolio along with dozens of OncoCell MDx, Inc. Clinical Trials and PubMed Articles about OncoCell MDx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of OncoCell MDx, Inc. Companies in our database. You can also find out about relevant OncoCell MDx, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record